NORDMANN RONALD M 4
4 · PAR PHARMACEUTICAL COMPANIES, INC. · Filed Mar 21, 2012
Insider Transaction Report
Form 4
NORDMANN RONALD M
Director
Transactions
- Sale
Common Stock
2012-03-19$37.06/sh−304$11,266→ 4,536 total - Sale
Common Stock
2012-03-19$37.04/sh−1,803$66,783→ 6,043 total - Sale
Common Stock
2012-03-19$37.02/sh−507$18,769→ 8,053 total - Sale
Common Stock
2012-03-19$37.03/sh−207$7,665→ 7,846 total - Exercise/Conversion
Common Stock
2012-03-19$28.79/sh+7,500$215,925→ 11,500 total - Sale
Common Stock
2012-03-19$37.08/sh−136$5,043→ 4,100 total - Sale
Common Stock
2012-03-19$37.05/sh−1,203$44,571→ 4,840 total - Sale
Common Stock
2012-03-19$37.07/sh−300$11,121→ 4,236 total - Exercise/Conversion
Common Stock, Option to Buy
2012-03-19−7,500→ 0 totalExercise: $28.79From: 2003-06-12Exp: 2012-06-11→ Common Stock (7,500 underlying) - Sale
Common Stock
2012-03-19$37.01/sh−2,940$108,815→ 8,560 total - Sale
Common Stock
2012-03-19$37.09/sh−100$3,709→ 4,000 total
Footnotes (1)
- [F1]Mr. Nordmann was granted an option to purchase 7,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on June 12, 2002, all of which vested on June 12, 2003. The expiration date of this option is June 11, 2012.